This followed an initial 10 years enrolment of 1,000 cases and 1,000 controls to understand the genetic susceptibility of prostate cancer among men of African ancestry between 2008 and 2019 which was initially hosted at Mulago National referral hospital.
Study period: 2022-2026
Principal Investigator: Dr. Stephen Watya (Uro Care/AMBSO), Dr. Christopher Haiman (USC)
Study Sponsor: National cancer institute of the National Institutes of Health (NIH)
Collaborating Institution: Keck School of Medicine of the University of Southern California (USC)
Study site: Multisite-Nationwide
Progress: Data collection is ongoing